Published in Gene Therapy Weekly, October 19th, 2006
"The Ras/Raf/MEK/ERK signalling cascade is frequently deregulated in tumourigenic diseases and known to be involved in proliferation and transformation of cells. Also in HCC increased ERK levels are observed and known to correlate with tumor progression, but the underlying molecular mechanism are unknown. We analyzed expression of RKIP in HCC," wrote M.M. Schuierer and colleagues, University of Regensburg.
"Expression of RKIP mRNA and protein was downregulated in HCC cell lines and tissue as compared to primary human hepatocytes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-10-19)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.